As Co-Founder and Director, contributions focus on creating tailored molecular remedies for complex diseases by utilizing molecules derived from human and animal microbiota. These efforts are guided by a commitment to GMP protocols and expertise in pharmaceutics. Since establishment of The BioArte in 2019 , the focus has expanded from deep diagnostics to personalized healthcare solutions driven by microbiome insights. These initiatives underscore a strong dedication to innovating precision medicine and advancing targeted therapeutic approaches, with the goal of transforming patient care through customized treatments.